Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report
Cureus · 28.04.2026
DOI: 10.7759/cureus.107914 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 28.04.2026. Verfasst von Yu Tsukasa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN.
Zitieren
APA
Tsukasa, Y., Sugimoto, Y., Yamamoto, T., Aoki, R., & Nakano, H. (2026). Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report. Cureus. https://doi.org/10.7759/cureus.107914
Vancouver
Tsukasa Y, Sugimoto Y, Yamamoto T, Aoki R, Nakano H. Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report. Cureus. 2026. doi:10.7759/cureus.107914
BibTeX
@article{Tsukasa2026,
author = {Tsukasa, Yu and Sugimoto, Yukihiro and Yamamoto, Takayuki and Aoki, Ryota and Nakano, Hirofumi},
title = {Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.107914}
}
EUVIMED